Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country

South African Medical Journal

Volumn 93, Issue 5, 2003, Pages 380-384

  Otedo, A E O ^a   Mc'Ligeyo, S O ^a   Okoth, F A ^b   Kayima, J K ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b MINISTRY OF HEALTH   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; ELECTROLYTE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M; LIVER ENZYME; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; COMORBIDITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; ELECTROLYTE BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HUMAN; KENYA; KIDNEY FAILURE; LABORATORY TEST; LETHALITY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PHYSICAL EXAMINATION; PREVALENCE; PUBLIC HOSPITAL; SCAR; SCREENING; SEROPREVALENCE; SPOUSE; STUDENT T TEST; TATTOO; UREA NITROGEN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HOSPITALS, PUBLIC; HUMANS; KENYA; KIDNEY FAILURE, CHRONIC; LIVER; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES; TIME;

EID: 0038517981     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Saraswat S, Banerjee K, Chaudhry N, et al. Post transfusion hepatitis B following multiple transfusions of HBsAg negative blood. J Hepatol 1996; 25: 639-643.
2. Cendorolo NM, Draibe SA, Silva EA, et al. Incidence of and risk factors for HBV and HCV infection among HD and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240 - 246.
3. Muller GY, Zabaleta ME, Arminio A. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 41: 1055 - 1058.
4. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981 - 999.
5. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on dialysis. Clin Nephrol 1992; 38: 44 - 48.
6. Koeler PM. Dialysis associated hepatitis. In: Horl WH, Ronco C, Winchester JF, Koch KM, Lindsay RM, eds. Replacement of Renal Function by Dialysis. 5th ed. Dordrecht: Kluwer Academic Publishers, 2003: 905-918.
7. Savin EA, Vasil'ev AN, Paskonkina OV, Os'Mirko TV. The characteristics of the epidemic process in hepatitis B, C and D in haemodialysis units and the experience of the vaccinal prevention of HBV infection in a delimited population. Russia. Ter Arkh 1995; 67: 13 - 15.
8. Goudeau A, Dubois F. Incidence and prevalence of hepatitis B in France. Vaccine 1995; 13: suppl 1, S22 - S25.
9. Shaskhgil'dian IV, Khukhlovich PA, Savin EA, et al. Risk of infection with hepatitis B and C viruses of medical workers, patients in haemodialysis wards, and vaccine prophylaxis of hepatitis B infection in this population. Russian. Vopr Virusol 1994; 39: 226 - 229.
10. Feitelson MA, Duan LX, Guoj K, et al. Precore and X region mutants in hepatitis B virus infections among renal dialysis patients. J Virol Hep 1995; 2: 19 - 31.
11. Cheng CH, Cheng TC, Lee SH, Shu KH, Wu MY. Increased serum transaminase levels in hepatitis C infectious haemodialysis patients: correlation with HCV viraemi and immunoblot. Nephrology 1997; 3: suppl 1, 164.
12. Barril G, Traver JA. Hepatitis virus prevalence in relation to modality of dialysis. Results after 4 years in 97 Spanish centers. Nephrology 1997; 3: suppl 1, 168.
13. Soni PN, Tait DR, Kenoyer DG. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 1993; 40: 65 - 68.
14. Fang J, Lav J. Controlling hepatitis C, a killer unmasked. J Innov Health 1997; 2: 38 - 41.
15. Ng YY, Lee SD, Wu SC, Huang GTP. Hepatitis C viral infection in haemodialysis patients: Clinical and molecular studies. Nephrology 1997; 3: suppl 1, 166.
16. Okoth FA. Viral hepatitis. East Afr Med J 1996; 73: 308-312.
17. Ilako FM, Mcligeyo SO, Riyat MS, Lule GN, Okoth FA, Kaptich D. The prevalence of hepatitis C virus antibody in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J 1995; 72: 362-364.
18. Oesterreicher C, Hammer J, Koch U, Pfeffel F, Sunder-Plassmann D, Muller C. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic haemodialysis. Kidney Int 1995; 48; 1967 - 1971.
19. Alter MJ, Margolis HS, Krawezynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Countries Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899 - 1905.
20. DuBois DB, Gretch D, Dela Rosa C, et al. Quantitation of hepatitis C viral RNA in sera of haemodialysis patients. Gender related differences in viral load. Am J Kidney Dis 1994; 24: 795-801.
21. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of haemodialysis-associated non-A, non-B hepatitis and correlation with antibody for hepatitis C virus. Am J Kidney Dis 1992; 19: 345 - 352.
22. Dussol B, Chicheportiche C, Cantaloube JF, et al. Detection of hepatitis C infection by polymerase chain reaction among haemodialysis patients. Am J Kidney Dis 1993; 22: 574-580.
23. Saho JF, Haukenes G, Yangi E, Vollset SE. Association of HBV and HIV infections in Tanzanian population groups. Eur J Clin Microbiol Infect Dis 1993; 12: 62-64.
24. William M, Lee MD. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.